Vericel Corp. (VCEL)
35.15
-0.25
(-0.71%)
USD |
NASDAQ |
May 21, 16:00
35.12
-0.03
(-0.09%)
After-Hours: 19:59
Vericel Research and Development Expense (TTM) : 28.41M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Marker Therapeutics, Inc. | 11.51M |
| Arbutus Biopharma Corp. | 20.40M |
| Tenaya Therapeutics, Inc. | 62.37M |
| Moderna, Inc. | 2.69B |
| Curis, Inc. | 26.16M |